Using HPV prevalence to predict cervical cancer incidence

Persistence of Type-Specific Human Papillomavirus Infection and Increased Long-term Risk of Cervical Cancer

(2011) H.-C. Chen et al.   JNCI-Journal of the National Cancer Institute

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings

(2010) Laia Bruni et al.   JOURNAL OF INFECTIOUS DISEASES

Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence

(2010) S. K. Kjaer et al.   JNCI-Journal of the National Cancer Institute

International Correlation between Human Papillomavirus Prevalence and Cervical Cancer Incidence

(2008) D. Maucort-Boulch et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Epidemiology and Prevention of Human Papillomavirus and Cervical Cancer in China and Mongolia

(2008) Ju-Fang Shi et al.   VACCINE